Plastic Surgery Educational Foundation   Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01244698
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

cefadroxil (duricef) (1 trial)

levobupivacaine (chirocaine) (1 trial)

sodium chloride (2 trials)

Drugs in Phase 3 Trials (1)

ropivacaine (naropin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 4)

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4